CDKN2A and neoplasm: Since short-term treatment with PD provided evidence that PD can successfully reach the tumor in the brainstem and inhibit cell growth we were interested to determine if PD would prolong the survival benefit of PDGF-B driven, Ink4a-ARF deficient BSGs.